Rowe JM - Search Results

1

Autologous transplant remains the preferred therapy for relapsed APL in CR2.

Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Zhang MJ, Weisdorf D, Douer D, Rowe JM, Polge E, Esteve J, Nagler A, Mohty M, Tallman MS. Ganzel C, et al. Among authors: rowe jm. Bone Marrow Transplant. 2016 Sep;51(9):1180-3. doi: 10.1038/bmt.2016.96. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088379 Free PMC article.

2

Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.

Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF. Rapoport AP, et al. Among authors: rowe jm. Bone Marrow Transplant. 1991 Nov;8(5):421-4. Bone Marrow Transplant. 1991. PMID: 1768978

3

Cardiac arrest after autologous marrow infusion.

Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ. Rapoport AP, et al. Among authors: rowe jm. Bone Marrow Transplant. 1991 May;7(5):401-3. Bone Marrow Transplant. 1991. PMID: 2070152

4

Treatment of refractory acute leukaemia with aclacinomycin A.

Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:47-8. Bone Marrow Transplant. 1989. PMID: 2627607 No abstract available.

5

Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature.

Dann EJ, Gillis S, Rowe JM. Dann EJ, et al. Among authors: rowe jm. Leukemia. 1995 Jun;9(6):1072-4. Leukemia. 1995. PMID: 7596172 Review.

6

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH. Tallman MS, et al. Among authors: rowe jm. J Clin Oncol. 1995 Jul;13(7):1557-63. doi: 10.1200/JCO.1995.13.7.1557. J Clin Oncol. 1995. PMID: 7602344 Clinical Trial.

7

Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma.

Heal JM, Blumberg N, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM. Heal JM, et al. Among authors: rowe jm. Bone Marrow Transplant. 1994 Dec;14(6):943-8. Bone Marrow Transplant. 1994. PMID: 7711672

8

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Among authors: rowe jm. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

9

Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors.

Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM. Rapoport AP, et al. Among authors: rowe jm. Bone Marrow Transplant. 1997 May;19(9):883-90. doi: 10.1038/sj.bmt.1700772. Bone Marrow Transplant. 1997. PMID: 9156261

10

Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?

Bennett CL, Golub R, Waters TM, Tallman MS, Rowe JM. Bennett CL, et al. Among authors: rowe jm. Cancer Invest. 1997;15(3):227-36. doi: 10.3109/07357909709039720. Cancer Invest. 1997. PMID: 9171857 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters